Benefit of Bone Drug in Prostate Cancer in Doubt - MedPage Today

USA TODAY

Benefit of Bone Drug in Prostate Cancer in Doubt MedPage Today Amgen would like to expand the indication to make the biologic available as a preventive treatment for men with castrate-resistant prostate cancer at high risk of developing bone metastases. The FDA's Oncologic Drugs Advisory Committee will meet ... FDA questions Amgen drug for prostate cancerUSA TODAY FDA Questions Benefit of Amgen Bone Drug in Certain CasesWall Street Journal (blog) Can Amgen Convince Docs to Recommend Approval?DailyFinance GlobalPost all 222 news articles »

Prostate Cancer Bone Mets Target of New Agent - MedPage Today

ThirdAge

Prostate Cancer Bone Mets Target of New Agent MedPage Today This placebo-controlled trial found an overall survival benefit from a novel alpha-pharmaceutical, radium-223 chloride, in the treatment of castration-resistant prostate cancer with existing bone metastases. Skeletal-related events -- including spinal ... Prostate Cancer Drug Protects Bone Health, Boosts SurvivalThirdAge Expanded Access Program for investigational drug Alpharadin (radium-223 ...Reuters (press release) Bayer Initiates Expanded Access Program for Investigational Compound Radium ...MarketWatch (press release) all 18 news articles »